Presentation on theme: "January 2008 May 2008. Mission Statement The fetus care BioPad™’s mission is to become a world leader in the field of pre-natal care by making consumer-based."— Presentation transcript:
Mission Statement The fetus care BioPad™’s mission is to become a world leader in the field of pre-natal care by making consumer-based medical devices that improve the pregnancy experience for women and their families.
Introducing Biopad’s Fetal Monitors The fetus care BioPad makes home-use fetal activity detectors and data loggers Products are passive and non- radiating Small, convenient, elegant and hygienic Can be used anywhere, anytime.
Scientific evidence suggests fetal activity is a clear indicator of wellbeing A common medical practice is a daily manual fetal kick count by the mother (‘count to 10’) Kick count is directly linked to lower stillbirth rates (20%-30%) Research also shows that kick counting improves the pregnancy experience Why Fetal Movements ? The fetus care
The fetus care Monitoring Reassurance Procedure Discerning Bonding Dialog Connecting Customer Needs
The Products – Kicker Ticker 2 The fetus care Medical device that requires FDA approval Consists of device (for single pregnancy) and disposable pad (one for each test) Provides automatic and accurate monitoring Counts and stores fetal movements (trends) Shows real-time results Sounds & light indications Data output (via USB) to be shared with doctor Each session lasts 20 minutes and can take place anywhere
The fetus care Prototype Testing Completed Successfully!
The Products – Kicker Ticker 1 The fetus care Non-medical, pregnancy experience focused Intended to share movements with family members and friends The Companion Egg™ responds to movements with tactile and light elements, creating tangible “event” Does not require FDA approval Fast time to market Movements Light Sounds
Substantial Sales Potential KT2 costs to woman - $120 KT1 costs to woman- $80 Family set - $150 (Includes sensor & 3 Companion Eggs™) Potential of +$100 million in income in year 5 of operations
Company Needs $2 - $3 million second round financing Strategic partnerships: Manufacturing Distribution Marketing The fetus care
Hanoch Kaftzan BioPad CEO T: 972.3.6093085 M: 972.52.6299629 F:972.3.6093089 Ayalon House, 16th floor 12 Abba Hillel St. Ramat Gan PO Box 25290, Tel Aviv 61251